![Jöerg Windisch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jöerg Windisch
Direttore/Membro del Consiglio presso Polpharma Biologics Utrecht BV
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Randy Thurman | M | 74 | 6 anni | |
Abraham Bout | M | - |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | 17 anni |
Bernhard R. M. Ehmer | M | 69 | 8 anni | |
Jerzy Starak | M | 76 |
Polpharma Biologics Group BV
| - |
Jennifer Kissner | M | - | 5 anni | |
Terry Dagnon | M | 62 | 6 anni | |
Michel Martinus Gerardus Cup | M | 54 |
Polpharma Biologics Group BV
| - |
Hannes Teissl | M | - |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | - |
Jan Willem Slob | M | 70 |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | - |
Konstantin Matentzoglu | M | - |
Polpharma Biologics Group BV
| - |
Jeff Evanson | M | 55 | 6 anni | |
Jonathan Robinson | M | - |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | 4 anni |
Georg Nederegger | M | 62 |
Polpharma Biologics Group BV
| - |
Gertjan Noordermeer | M | - |
Polpharma Biologics Group BV
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Scott Canute | M | 63 | 7 anni | |
Johannes Schwertner | M | 58 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | - |
Anette Weber | F | 53 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 5 anni |
Shreeram Aradhye | M | 62 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 2 anni |
Peter Goldschmidt | M | 59 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 4 anni |
Christina Ackermann | F | 59 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 5 anni |
Vasant Narasimhan | M | 48 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | - |
Stephen McAndrew | M | - | - | |
Richard Francis | M | 55 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 5 anni |
Ameet Mallik | M | 51 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 5 anni |
Kenneth Bahrt | M | 71 | 4 anni | |
Myrna Thomas | F | - | - | |
Brigittes Schrätzenstaller-Rauch | F | - |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 3 anni |
Helmut Jeggle | M | 53 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 2 anni |
Claudio Albrecht | M | 64 | 1 anni | |
Shannon Klinger | M | 53 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 4 anni |
Birgit Kudlek | M | 57 |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | 4 anni |
Cassandra Choe-Juliak | M | - | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Germania | 14 | 43.75% |
Paesi Bassi | 9 | 28.13% |
Stati Uniti | 9 | 28.13% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jöerg Windisch
- Contatti personali